Information on biocides
Information on biocides
Information on biocides
The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product must be authorised before it can be made available on the market or used in the European Economic Area (EEA) and Switzerland. This takes place in two consecutive steps. First, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type. The second step is the authorisation of each product consisting of, containing or generating the approved active substance(s). This page concerns the first step.
The data on this page is active substance/product-type centric. This is reflected in all the search filters and results of the searches. Subsequently the table below displays information per active substance/product-type combination. For efficiency reasons, the term active substance is used interchangeable with the term active substance/product-type combination.
The database includes active substances in the Review Programme, active substances not in the Review Programme as well as substances in Annex I of the BPR. More information on the categorisation of active substances can be read in Approval of active substances page.
For further information on searches you can perform and how the information is presented please read on.
How to search
You can view the information on biocidal active substances in two ways:
- per specific active substance and product-type combination (use the Search tab); and
- as a summary of all product-type applications that have been submitted for a given active substance (Summary tab).
Using the Search tab, you can search with:
- Active substance details: substance identifiers, product-type, candidate for substitution.
(The default status for the field Candidate for substitution is “under assessment” and this status does not necessarily imply that the active substance is suspected Candidate for substitution. Provided the active substance is identified or not as a potential candidate for substitution, the status on the dissemination page changes accordingly to “yes” or “no”.)
- Approval data: for example the status of an application for approval, the assessment step in the approval process, validity of the approval granted.
- Related authorised biocidal products (trade name of a biocidal product).
How the information is presented
The results table presents information on an active substance, such as approval start and end date, evaluating competent authority and approval or assessment status. The substance name is a link to the substance information page (Infocard) which summarises information on a substance from all regulatory contexts managed by ECHA.
The data on active substances is collected from the Register for Biocidal Products (R4BP 3). It covers information on active substances for which an application for approval for a specific biocidal product-type has been submitted under the BPR or Biocidal Products Directive (Directive 98/8/EC). Please note that the validation step in R4BP 3 must be successfully passed for active substances to be disseminated or for the most recent status in the application process to be displayed.
More information on a specific active substance approval can be found in the factsheet (accessible through the eye icon in the results table). The factsheet holds details on the latest approval data, including relevant documents, related authorised biocidal products, and an overview of all the changes on the active substance approval.
In the results table, the number of related authorised biocidal products is also visible. The number represents the count of product clusters (groups of authorisations) containing the given active substance.
The Summary tab lists all product-type applications that have been submitted for a given active substance, regardless approval has been granted or refused. The approval status of an active substance and product-type combination is described with an icon. Hovering your mouse over the icon, you can see the status of an application for approval, the assessment step if the approval process is ongoing, and you can access the active substance factsheet.
Export results
You can export the active substance results to the ECHA website standard formats (XLS, CSV and XML).
Due to a technical problem, which is being fixed, certain substance/product-type combinations are currently displayed with an inaccurate status.
Further information
- List of approved active substances
- Approval of active substances
- Understanding the BPR Regulation
- Q&A on Biocidal Products Regulation
- Give us your feedback
- BPC opinions on approval of active substances
- Public consultation on potential candidates for substitution
- Lists of Member States where wood treated with creosote may be placed on the market for certain uses [EN][PDF]
Note that the information is directly from the Member States
Last updated 30 marts 2023. Database contains 929 active substance-product type and Annex I records for which approval has been sought.
| Annex I Substance (+)-Tartaric acid | 201-766-0 | 87-69-4 | 01/09/2013 |
- |
Approved | Link to the factsheet | 62 | ||
| (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin) |
-; 214-619-0 |
1166-46-7 | PT18 icon PT18 |
Germany |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (13Z)-Hexadec-13-en-11-yn-1-yl acetate | 642-968-2 | 78617-58-0 | PT19 icon PT19 |
France |
Initial application for approval in progress
Commission decision |
Link to the factsheet | 1 | ||
| (2R,6aS,12aS)-1,2,6,6a,12,12a-hexa hydro-2-isopropenyl-8,9-dimethoxychro meno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone) |
-; 201-501-9 |
83-79-4 | PT17 icon PT17 |
United Kingdom |
Cancelled application | Link to the factsheet | |||
| Annex I Substance (9Z,12E)-tetradeca-9,12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | 01/09/2013 |
- |
Approved | Link to the factsheet | 17 | ||
| (benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) |
-; 244-445-0 |
21564-17-0 | PT09 icon PT09 |
Norway |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) |
-; 244-445-0 |
21564-17-0 | PT12 icon PT12 |
Norway |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzyloxy)methanol |
-; 238-588-8 |
14548-60-8 | PT06 icon PT06 |
Austria |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzyloxy)methanol |
-; 238-588-8 |
14548-60-8 | PT13 icon PT13 |
United Kingdom |
No longer supported | Link to the factsheet | |||
| (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | PT08 icon PT08 | 01/02/2010 | 31/01/2020 |
Germany |
Expired | Link to the factsheet | |
| (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | PT18 icon PT18 | 01/10/2016 | 30/09/2026 |
Germany |
Approved | Link to the factsheet | 5 |
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
-; 222-720-6 |
3586-55-8 | PT02 icon PT02 |
Poland |
No longer supported | Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
-; 222-720-6 |
3586-55-8 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
-; 222-720-6 |
3586-55-8 | PT11 icon PT11 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
-; 222-720-6 |
3586-55-8 | PT12 icon PT12 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) |
-; 222-720-6 |
3586-55-8 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl (1R,3R)-2,2-dimethyl-3-(2-methyl prop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin) | - | 260359-57-7 | PT18 icon PT18 |
Germany |
Not approved | Link to the factsheet | |||
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R; 1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin) |
- | 231937-89-6 | PT18 icon PT18 |
Germany |
Not approved | Link to the factsheet | |||
| (RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) |
-; 257-842-9 |
52315-07-8 | PT08 icon PT08 | 01/06/2015 | 31/05/2025 |
Belgium |
Approved | Link to the factsheet | 69 |
| (RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) |
-; 257-842-9 |
52315-07-8 | PT18 icon PT18 | 01/06/2020 | 31/05/2030 |
Belgium |
Approved
-
Other updates in progress
- |
Link to the factsheet | 6 |
| (Z,E)-tetradeca-9,12-dienyl acetate | - | 30507-70-1 | PT19 icon PT19 |
Austria |
No longer supported | Link to the factsheet | 12 | ||
| .alpha.-cyano-3-phenoxybenzyl2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin) |
-; 254-484-5 |
39515-40-7 | PT18 icon PT18 | 01/02/2020 | 31/01/2030 |
Greece |
Approved | Link to the factsheet | |
| .alpha.-cyano-4-fluoro-3-phenoxybenzyl3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cyfluthrin) |
-; 269-855-7 |
68359-37-5 | PT18 icon PT18 | 01/03/2018 | 28/02/2028 |
Germany |
Approved | Link to the factsheet | 13 |
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT02 icon PT02 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT06 icon PT06 |
Spain |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT09 icon PT09 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT10 icon PT10 |
Spain |
No longer supported | Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT11 icon PT11 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT12 icon PT12 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) |
-; 220-120-9 |
2634-33-5 | PT13 icon PT13 |
Spain |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) |
-; 229-222-8 |
6440-58-0 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Opinion development by BPC |
Link to the factsheet | |||
| 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) |
-; 229-222-8 |
6440-58-0 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Opinion development by BPC |
Link to the factsheet | |||
| 1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl) urea (Hexaflumuron) |
-; 401-400-1 |
86479-06-3 | PT18 icon PT18 | 01/04/2017 | 30/09/2024 |
Greece |
Approved
-
Renewal in progress
Competent authority evaluation |
Link to the factsheet | |
| 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil) |
-; 252-615-0 |
35554-44-0 | PT03 icon PT03 |
Germany |
No longer supported | Link to the factsheet | |||
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) |
-; 262-104-4 |
60207-90-1 | PT07 icon PT07 | 01/12/2016 | 30/11/2026 |
Finland |
Approved | Link to the factsheet | 1 |
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) |
-; 262-104-4 |
60207-90-1 | PT08 icon PT08 | 01/04/2010 | 31/12/2023 |
Finland |
Approved
-
Renewal in progress
Commission decision |
Link to the factsheet | 947 |
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) |
-; 262-104-4 |
60207-90-1 | PT09 icon PT09 | 01/06/2015 | 31/05/2025 |
Finland |
Approved | Link to the factsheet | |
| 1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin) |
-; 259-154-4 |
54406-48-3 | PT18 icon PT18 |
Belgium |
Not approved | Link to the factsheet | |||
| 1R-trans phenothrin |
-; 247-431-2 |
26046-85-5 | PT18 icon PT18 | 01/09/2015 | 31/08/2025 |
Ireland |
Approved | Link to the factsheet | 34 |
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT02 icon PT02 |
Denmark |
Initial application for approval in progress
Notified |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT04 icon PT04 |
Denmark |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT06 icon PT06 |
Denmark |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT11 icon PT11 |
Denmark |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT12 icon PT12 |
Denmark |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) |
-; 233-539-7 |
10222-01-2 | PT13 icon PT13 |
Denmark |
No longer supported | Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) |
-; 225-208-0 |
4719-04-4 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) |
-; 225-208-0 |
4719-04-4 | PT11 icon PT11 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) |
-; 225-208-0 |
4719-04-4 | PT12 icon PT12 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) |
-; 225-208-0 |
4719-04-4 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′-dithiobis[N-methylbenzamide] (DTBMA) |
-; 219-768-5 |
2527-58-4 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
EU Privacy Disclaimer
Dette websted anvender cookies for at sikre dig den bedste brugeroplevelse.